Radius Health, Inc.
RDUS
RDUS was delisted on the 12th of August, 2022.
132 hedge funds and large institutions have $878M invested in Radius Health, Inc. in 2020 Q4 according to their latest regulatory filings, with 16 funds opening new positions, 42 increasing their positions, 47 reducing their positions, and 16 closing their positions.
60% more capital invested
Capital invested by funds: $548M → $878M (+$330M)
2% more call options, than puts
Call options by funds: $2.57M | Put options by funds: $2.51M
0% more funds holding
Funds holding: 132 → 132 (0)
0% more first-time investments, than exits
New positions opened: 16 | Existing positions closed: 16
11% less repeat investments, than reductions
Existing positions increased: 42 | Existing positions reduced: 47
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
T. Rowe Price Associates
Baltimore,
Maryland
|
+$22.4M |
| 2 |
Wellington Management Group
Boston,
Massachusetts
|
+$14.3M |
| 3 |
Morgan Stanley
New York
|
+$6.66M |
| 4 |
BNP Paribas Asset Management
Paris,
France
|
+$5.98M |
| 5 |
Two Sigma Investments
New York
|
+$3.41M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
RCMNY
Rubric Capital Management (New York)
New York
|
-$9.89M |
| 2 |
RSCM
Rock Springs Capital Management
Baltimore,
Maryland
|
-$9.23M |
| 3 |
Goldman Sachs
New York
|
-$6.77M |
| 4 |
SCM
Sio Capital Management
New York
|
-$6.03M |
| 5 |
Renaissance Technologies
New York
|
-$3.21M |
RDUS Hedge Fund Activity: Q4 2020 in Review
132 of the 5,651 institutional investors tracked by Wall St. Rank reported a position in Radius Health, Inc. (RDUS) for Q4 2020, worth a combined $878M — up 60% from $548M a quarter earlier.
Fund positioning in RDUS was balanced in Q4 2020: 16 funds opened new positions, 16 closed out, 42 added to existing stakes and 47 trimmed.
The largest buyer was T. Rowe Price Associates, adding an estimated $22.4M. The largest seller was Rubric Capital Management (New York), cutting an estimated $9.89M.
- 132 institutional investors held Radius Health, Inc. (RDUS) as of Q4 2020, unchanged from Q3 2020.
- Funds reported $878M of Radius Health, Inc. stock for Q4 2020, up 60% quarter-over-quarter.
- 16 funds opened new Radius Health, Inc. positions in Q4 2020 and 16 closed out, a net change of 0 holders.
- The largest Radius Health, Inc. buyer in Q4 2020 was T. Rowe Price Associates, an estimated $22.4M added.
- The largest Radius Health, Inc. seller in Q4 2020 was Rubric Capital Management (New York), an estimated $9.89M sold.
Based on aggregated 13F filings for Q4 2020.